Zephyr AI
Our AI-Enabled platform leverages the combined scale and diversity of healthcare and biological data to uncover hidden insights that allow us match patients to drugs and reveal biological context that can be used to make developing new drugs faster and more efficient.
Zephyr AI
At Zephyr we're building a team of highly motivated experts who: Thrive in cross disciplinary environments. Revel in the continuous cycle of learning and teaching, fostering a culture of intellectual growth.
Zephyr AI
Zephyr's machine learning models seamlessly integrate clinical and molecular patient features with drug structures and targets, enabling the prediction of drug response and the identification of gene networks critical to tumor survival.
Zephyr AI
Zephyr AI Raises $111 Million in Series A Financing. March 13, 2024. Zephyr AI Demonstrates Predictive Value of Artificial Intelligence (AI) with RWD for Label Expansion with Approved 3rd Generation EGFR Inhibitor at the 2023 ASCO Annual Meeting. June 2, 2023.
Zephyr AI
Jun 4, 2024 · Zephyr AI SITC 2023 Poster: TME from NGS panels. November 1–5, 2023 - San Diego, CA. Reconstructing gene expression from clinical and genetic panel data for predictions of tumor microenvironment features and response to immune checkpoint inhibitor therapy.
Zephyr AI
Work at Zephyr AI. We are a multidisciplinary team of world-class software engineers, scientists, and entrepreneurs dedicated to leveraging big data and cutting-edge technology to derive transformational insights, build enduring partnerships aimed at revolutionizing the treatment of cancer, diabetes, and other diseases.
Zephyr AI
Contact Us. If you are interested in working for Zephyr but do not see a specific open role you would like to apply for, please apply via the "General Submission" listing on the careers page.
Zephyr has developed an AI/ML method that integrates and harnesses insights from large, diverse and disparate multi-modal datasets, to create a novel patient selection tool that uniquely advances precision medicine.
Zephyr AI is curating the worldʼs most comprehensive healthcare dataset and marrying it with cutting-edge artificial intelligence algorithms. We generate novel, translatable insights to build tools and products that support patients and providers and fuel ongoing research.
We developed systems biology-informed AI methods trained on vast multi-omics and multi-modal datasets from DepMap, TCGA and other publicly available sources, to uncover latent vulnerabilities existing in tumors (Figure 1).